[HTML][HTML] Pathogenic pathways and therapeutic approaches targeting inflammation in diabetic nephropathy

S Rayego-Mateos, JL Morgado-Pascual… - International journal of …, 2020 - mdpi.com
Diabetic nephropathy (DN) is associated with an increased morbidity and mortality, resulting
in elevated cost for public health systems. DN is the main cause of chronic kidney disease …

Inflammation and the pathogenesis of diabetic nephropathy

J Wada, H Makino - Clinical science, 2013 - portlandpress.com
The most problematic issue in clinical nephrology is the relentless and progressive increase
in patients with ESRD (end-stage renal disease) worldwide. The impact of diabetic …

Neuroinflammation and the generation of neuropathic pain

A Ellis, DLH Bennett - British journal of anaesthesia, 2013 - academic.oup.com
Inflammation is the process by which an organism responds to tissue injury involving both
immune cell recruitment and mediator release. Diverse causes of neuropathic pain are …

The association of cell adhesion molecules and selectins (VCAM-1, ICAM-1, E-selectin, L-selectin, and P-selectin) with microvascular complications in patients with …

K Siddiqui, TP George, M Mujammami… - Frontiers in …, 2023 - frontiersin.org
Objective Chronic hyperglycemia induces pathogenic changes in the vascular endothelium
and leads to the development of microvascular complications in patients with type 2 …

[HTML][HTML] Kidney protection effects of dihydroquercetin on diabetic nephropathy through suppressing ROS and NLRP3 inflammasome

T Ding, S Wang, X Zhang, W Zai, J Fan, W Chen… - Phytomedicine, 2018 - Elsevier
Background Diabetic nephropathy (DN), the leading cause of end-stage renal disease, is
acknowledged as an independent risk factor for cardiovascular disease, which underlines …

Inflammation, oxidative stress, apoptosis, and autophagy in diabetes mellitus and diabetic kidney disease: the Four Horsemen of the Apocalypse

K Turkmen - International urology and nephrology, 2017 - Springer
Diabetic kidney disease (DKD) can occur in approximately 30–40% of both type 1 and type
2 diabetic patients. The well-established features of DKD include increased serum glucose …

Kidney disease in diabetic patients: from pathophysiology to pharmacological aspects with a focus on therapeutic inertia

G Gembillo, Y Ingrasciotta, S Crisafulli, N Luxi… - International journal of …, 2021 - mdpi.com
Diabetes mellitus represents a growing concern, both for public economy and global health.
In fact, it can lead to insidious macrovascular and microvascular complications, impacting …

Black seed thymoquinone improved insulin secretion, hepatic glycogen storage, and oxidative stress in streptozotocin‐induced diabetic male wistar rats

HMA Abdelrazek, OE Kilany… - Oxidative medicine …, 2018 - Wiley Online Library
Diabetes mellitus is one of the metabolic diseases having several complications. Nigella
sativa oil (NSO) might have beneficial effects in the treatment of diabetic complications …

Association of epicardial adipose tissue, neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio with diabetic nephropathy

EM Akbas, L Demirtas, A Ozcicek… - … journal of clinical …, 2014 - pmc.ncbi.nlm.nih.gov
Background: The relationship between diabetic nephropathy, visceral adipose tissue (VAT),
and inflammation has been shown. The neutrophil-to-lymphocyte ratio (NLR) and platelet-to …

Targeting aldose reductase for the treatment of diabetes complications and inflammatory diseases: new insights and future directions

R Maccari, R Ottanà - Journal of medicinal chemistry, 2015 - ACS Publications
Aldose reductase (AR) is an aldo–keto reductase that has been widely investigated as an
enzyme crucially involved in the pathogenesis of chronic complications associated with …